CVE-2026-21923

Severity: medium (CVSS 6.5 v3.1)
Exploited in the wild: not listed in CISA KEV
EPSS: 0.3% probability of exploitation in the next 30 days
Public exploit or detection template: none known
Published: 2026-01-20 · updated 2026-06-17

Description

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Designer accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).

Affected products

Oracle Corporation Oracle Life Sciences Central Designer: 7.0.1.0

References

https://www.oracle.com/security-alerts/cpujan2026.html

Get alerted when CVE-2026-21923 or the next vulnerability affects your stack